StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.42−0.07 (-4.70%)

Close on Nov 16, 2026Market cap $36.18MP/E –Yield –

BioRestorative Therapies total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioRestorative Therapies's total debt was $5.64M at Sep 30, 2021. For fiscal 2020 it was $4.27M, up 715.1% from the year before. The highest annual figure on record is $4.27M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$4.27M+715.1%
FY2018Dec 31, 2018$523.89K+169.7%
FY2017Dec 31, 2017$194.28K-34.8%
FY2016Dec 31, 2016$297.76K-1.4%
FY2015Dec 31, 2015$302.00K+504.0%
FY2014Dec 31, 2014$50.00K-90.5%
FY2013Dec 31, 2013$524.00K-85.4%
FY2012Dec 31, 2012$3.59M–
FY2011Dec 31, 2011$0-100.0%
FY2010Dec 31, 2010$196.88K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2021Sep 30, 2021$5.64M+3490.6%
Q2 FY2021Jun 30, 2021$4.78M+2282.4%
Q1 FY2021Mar 31, 2021$4.48M+817.1%
Q4 FY2020Dec 31, 2020$4.27M+715.1%
Q3 FY2019Sep 30, 2019$157.14K-86.8%
Q2 FY2019Jun 30, 2019$200.80K-45.5%
Q1 FY2019Mar 31, 2019$488.11K+478.6%
Q4 FY2018Dec 31, 2018$523.89K+169.7%
Q3 FY2018Sep 30, 2018$1.19M+1830.6%
Q2 FY2018Jun 30, 2018$368.72K+207.0%
Q1 FY2018Mar 31, 2018$84.36K-38.7%
Q4 FY2017Dec 31, 2017$194.28K-34.8%
Q3 FY2017Sep 30, 2017$61.69K-87.3%
Q2 FY2017Jun 30, 2017$120.12K-75.9%
Q1 FY2017Mar 31, 2017$137.63K–
Q4 FY2016Dec 31, 2016$297.76K–
Q3 FY2016Sep 30, 2016$487.00K–
Q2 FY2016Jun 30, 2016$499.34K–

More BioRestorative Therapies figures

See a number that looks wrong?